Combined impact of mucosal damage and of cystic fibrosis on the small intestinal brush border enzyme activities

Acta Clinica Belgica

Volumn 58, Issue 4, 2003, Pages 220-224

  Van Biervliet, S ^a   Eggermont, E ^a   Marien P ^a   Hoffman, I ^a   Veereman, G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Amylase; Chymotrypsin; Cystic fibrosis; Intestinal alkaline phosphatase; Lactase; Maltase; Small intestinal mucosa damage; Sucrase

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA GLUCOSIDASE; AMYLASE; CHYMOTRYPSIN; INTESTINE ENZYME; LACTASE; MEMBRANE PROTEIN; SUCRASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; BRUSH BORDER; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; GENE MUTATION; GLYCOPROTEIN SYNTHESIS; HUMAN; HUMAN TISSUE; INFANT; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; MAJOR CLINICAL STUDY; MICROSCOPY; MUCOSA INFLAMMATION; SMALL INTESTINE MUCOSA; SMALL INTESTINE MUCOSA DAMAGE; STOMACH CONTENT;

EID: 0242269500     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2003.58.4.002     Document Type: Article

References (28)

1. Van Biervliet S, Eggermont E, Carchon H, Veereman G, Deboeck K. Small intestinal brush border enzymes in cystic fibrosis. Acta Gastroenterol Belg. 1999; 62: 267-71.
2. Shmerling DH. Peroral intestinal mucosal biopsies in infants and children. Helv Paediatr Acta 1970: s22; 1-42.
3. Walker-Smith J. Diseases of the small intestine in childhood. London: Pitman Medical, 1975.
4. Eggermont E. Hydrolysis of naturally occurring alfa-glycosides by the human intestinal mucosa. Eur J Biochem. 1969; 9: 483-7.
5. Garen A, Levinthal C. A fine structure genetic and chemical study of the enzyme alkaline phosphatase of E.Coli. Purification and characterization of alkaline phosphatase. Biochem Biophys Acta. 1960; 38: 470-83.
6. Kaspar P, Moller G, Wahlefeld. A new photometric assay for chymotrypsin in stool. Clin Chem 1984; 30: 1753-1757.
7. Van Wieringen JC. Seculaire groeiverschuivingen. Leiden: Netherlands Institute for preventive Medicine, 1972.
8. Rosenstein BJ, Zeitlin PL. Cystic fibrosis. Lancet. 1998; 351: 277-82.
9. Walkowiak J, Herzig KH. Fecal etastase-1 is decreased in villous atrophy regardless of the underlying disease. Eur J Clin Invest 2001; 31: 425-430.
10. Antonowicz I, Lebenthal E, Shwachman H. Disaccharidase activities in small intestinal mucosa in patients with cystic fibrosis. J Pediatr. 1978; 92: 214-9.
11. Cox KL, Isenberg JN, Ament ME. Gastric hypersecretion in cystic fibrosis. J Pediatr Gastroenterol Nutr 1982; 1: 559-65.
12. Cameron DJ, Pitcher-Wilmott R, Milla PJ et al. The effect of cimetidine on meal-stimulated gastric function and exogenous pancreatic function in cystic fibrosis. Hum Nutr clin Nutr. 1982; 36: 475-81.
13. Hadorn B, Johansen PG, Anderson CM. Pancreozymin secretion test of exocrine pancreatic function in cystic fibrosis and the significance of the result for the pathogenesis of the disease. Canad Med Ass J 1968; 98: 377-385.
14. Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A. Intestinal inflammation in cystic fibrosis. Arch Dis Child. 2000; 82: 394-9.
15. Leclercq-Foucart I, Forget P, Sodoyez-Goffaux F, Zappitelli A. Intestinal permeability to (51 Cr) EDTA in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1986; 5: 384-7.
16. Sierra C, Valverde E, Ortega C, Picazo B, Martinez A, Sanchez-Font E. Intestinal permeability in children with cystic fibrosis: Lactulose/mannnitol, lactulose/cratinine and mannitol/creatinine ratios. J Clin Nutr Gastroenterol. 1993; 8: 94-9.
17. Nichols BL, Nichols VN, Putman M, Avery SE, Fraley JK, Quaroni A, Shiner M, Sterchi EE, Carrazza F. Contribution of villous atrophy to reduced intestinal maltase in infants with malnutrition. J Pediatr Gastroenterol Nutr 2000; 30: 494-502.
18. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990; 63: 827-34.
19. Rutishauser J, Spiess M. Endoplasmic reticulum storage diseases. Swiss med Wkly 2002; 132: 211-22.
20. Pradeep KD, Brasitus TA. Inactivation of rat small intestinal brush border membrane alkaline phosphatase by oxygen free radicals. Gastroenterology 1993; 105: 357-66.
21. Brown RK, Kelly FJ. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994; 36: 487-93.
22. Krebs NF, Sontag M, Accurso F, Hambidge KM. Low plasma zinc concentrations in young infants with cystic fibrosis. J Pediatr 1998; 133: 761-4.
23. Robinson PJ, Sly PD. High dose pancreatic enzymes in cystic fibrosis. Arch Dis Child 1990; 65: 311-12.
24. Laiho K, Gavin J, Murphy J, Connett G, Wootton S. Stool lipid in CF: Maldigestion or malabsorption? Pediatr Pulmonol 1999; S19: 302.
25. Kalivianikis M, Minich DM, Bijleveld CMA, van Aalderen WMC, Stellaard F, Laseur M, Vonk RJ, Verkade HJ. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 1999; 69: 127-34.
26. Shepherd RW, Cleghorn GJ. Cystic fibrosis: nutritional and intestinal disorders. Boca Raton Florida: CRC Press, 1953.
27. Ong DE. Retinoid metabolism during intestinal absorption. J Nutr 1993; 123: 351-5.
28. Brigelius-Flohé R, Kelly FJ, Salonen JT, Neuzil J, Zingg J-M, Azzi A. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 2002; 76: 703-16.